FDA takes action against 500 websites illegally selling prescription medicine

The FDA recently targeted more than 500 websites that illegally sold unapproved, potentially hazardous versions of prescription medicines such as opioids, antibiotics and epinephrine products.

Advertisement

These actions were a part of an international effort designed to curb the unlawful sale and distribution of illegal, counterfeit or ineffective medical products online. This effort, dubbed Operation Pangea X, took place Sept. 12 to Sept. 19.

As a result of the operation, the FDA seized nearly 100 website names, detained nearly 500 parcels for FDA compliance follow up and sent 13 warning letters to the operators of 401 websites. 

“These rogue online pharmacies are often run by sophisticated criminal networks that knowingly and unlawfully distribute illicit drugs, including counterfeit medicines and controlled substances,” said Scott Gottlieb, MD, the FDA’s commissioner. “Consumers go to these websites believing that they are buying safe and effective medications, but they are being deceived and put at risk by individuals who put financial gains above patient safety.”

This year’s operation was led by Interpol, an international police organization.

More articles on supply chain:
Express Scripts CMO: Healthcare system isn’t set up to pay for Novartis’ $475k cancer drug
WHO: The world has a serious lack of new antibiotics under development
Teva to sell remaining women’s health assets in 2 deals totaling $1.38B

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.